Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis: Results from IMPACT 2 trial

被引：0
|
作者：
Van der Heljde, D
Kavanaugh, A
Beutler, A
Guzzo, C
Zhou, B
Dooley, L
Antonl, CE
Krueger, GG
Gladman, D
机构：
[1] Univ Hosp Maastricht, Dept Rheumatol, Maastricht, Netherlands
[2] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA
[3] Centocor Inc, Clin Res & Dev, Malvern, PA 19355 USA
[4] Univ Erlangen Nurnberg, Dept Med 3, Erlangen, Germany
[5] Univ Utah, Hlth Sci Ctr, Dept Dermatol, Salt Lake City, UT USA
[6] Univ Toronto, Toronto Western Hosp, Toronto, ON M5T 2S8, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [31] Radiographic Progression of Structural Joint Damage in Patients with Active Psoriatic Arthritis Treated with Ixekizumab for up to 3 Years
    van der Heijde, Desiree
    Chandran, Vinod
    Fleischmann, Roy
    Benichou, Olivier
    Rathmann, Suchitrita
    Shuler, Catherine
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [32] Infliximab prevents progression of disability in patients with psoriatic arthritis
    Kavanaugh, A.
    Antoni, C.
    Krueger, G. G.
    Beutler, A.
    Zhou, B.
    Guzzo, C.
    Dooley, L.
    Bala, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 221 - 221
  • [33] The infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni, C
    Kavanaugh, A
    Kirkham, B
    Burmester, G
    Weisman, M
    Keystone, E
    Ebner, W
    Furst, D
    Wassenberg, S
    Grunke, M
    Schneider, U
    Tutuncu, Z
    Kalden, J
    Smolen, J
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S381 - S381
  • [34] Infliximab inhibits radiographic progression regardless of disease activity at baseline and following treatment in patients with early active rheumatoid arthritis
    Smolen, J. S.
    Han, C.
    Van der Heijde, D. M.
    Emery, R.
    Bathon, J. M.
    Keystones, E.
    Maini, R. N.
    Kalden, J. R.
    Aletaha, D.
    Baker, D.
    Han, J.
    Bala, M.
    St. Clair, E. W.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 188 - 188
  • [35] The Association Between Obesity and Radiographic Progression Of Joint Damage Among Patients With Psoriatic Arthritis
    Eder, Lihi
    Thavaneswaran, Arane
    Chandran, Vinod
    Cook, Richard J.
    Gladman, Dafna D.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S146 - S147
  • [36] Two-year data: Infliximab maintains clinical response in psoriatic arthritis patients - An analysis of the year 2 data from the infliximab multinational psoriatic arthritis controlled trial (impact)
    Antoni, CE
    Kavanaugh, A
    Kirkham, B
    Tutuncu, Z
    Burmester, GR
    Schneider, U
    Furst, DE
    Molitor, J
    Keystone, E
    Gladman, D
    Manger, B
    Wassenberg, S
    Weier, R
    Wallace, D
    Weisman, MH
    Kalden, JR
    Smolen, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 82 - 82
  • [37] Effect of Secukinumab on Radiographic Progression Through 2 Years in Patients with Active Psoriatic Arthritis: End-of-study Results from a Phase III Study
    Mease, Philip
    Landewe, Robert B. M.
    Rahman, Proton
    Tahir, Hasan
    Singhal, Atul
    Boettcher, Elke
    Navarra, Sandra
    Readie, Aimee
    Mpofu, Shephard
    Delicha, Evie Maria
    Pricop, Luminita
    van der Heijde, Desiree
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [38] Adalimumab treatment effects on radiographic progression of joint disease in patients with psoriatic arthritis: Results from ADEPT
    Mease, PJ
    Sharp, JT
    Ory, P
    Gladman, DD
    Ritchlin, CT
    Choy, EH
    Weinberg, MA
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 320 - 320
  • [39] Infliximab inhibits radiographic progression regardless of disease activity at baseline and following treatment in patients with early active rheumatoid arthritis.
    Smolen, J. S.
    Han, C.
    van der Heijde, D.
    Emery, P.
    Bathon, J. M.
    Keystone, E.
    Maini, R. N.
    Kalden, J. R.
    Aletaha, D.
    Baker, D.
    Han, J.
    Bala, M.
    St. Clair, E. W.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S231 - S231
  • [40] Infliximab prevents progression of disability in patients with psoriatic arthritis.
    Kavanaugh, A.
    Antoni, C.
    Krueger, G. G.
    Beutler, A.
    Zhou, B.
    Guzzo, C.
    Dooley, L.
    Bala, M.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S722 - S722
12345